Cargando…

Antibodies and tuberculosis

Tuberculosis (TB) remains a major public health problem internationally, causing 9.6 million new cases and 1.5 million deaths worldwide in 2014. The Bacillus Calmette-Guérin vaccine is the only licensed vaccine against TB, but its protective effect does not extend to controlling the development of i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jacobs, Ashley J., Mongkolsapaya, Juthathip, Screaton, Gavin R., McShane, Helen, Wilkinson, Robert J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Churchill Livingstone 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120988/ https://www.ncbi.nlm.nih.gov/pubmed/27865379 http://dx.doi.org/10.1016/j.tube.2016.08.001

Ejemplares similares

Recent advances in understanding dengue
por: Yacoub, Sophie, et al.
Publicado: (2016)

The immunology of Zika Virus
por: Culshaw, Abigail, et al.
Publicado: (2018)

Lectin Switching During Dengue Virus Infection
por: Dejnirattisai, Wanwisa, et al.
Publicado: (2011)

Why don’t we have an effective tuberculosis vaccine yet?
por: Davenne, Tamara, et al.
Publicado: (2016)

Sensing of Immature Particles Produced by Dengue Virus Infected Cells Induces an Antiviral Response by Plasmacytoid Dendritic Cells
por: Décembre, Elodie, et al.
Publicado: (2014)

Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus
por: Dejnirattisai, Wanwisa, et al.
Publicado: (2016)

The next 10 years for tuberculosis vaccines: do we have the right plans in place?
por: Meyer, Joel, et al.
Publicado: (2013)

Tuberculosis vaccines: beyond bacille Calmette–Guérin
por: McShane, Helen
Publicado: (2011)

Anti-Dengue E-dimer epitope human antibodies have therapeutic activity against Zika virus infection
por: Fernandez, Estefania, et al.
Publicado: (2017)

A Simplified Positive-Sense-RNA Virus Construction Approach That Enhances Analysis Throughput
por: Siridechadilok, Bunpote, et al.
Publicado: (2013)

Mucosal delivery of tuberculosis vaccines: a review of current approaches and challenges
por: Stylianou, Elena, et al.
Publicado: (2019)

Controlled Human Infection Models: Is it Really Feasible to Give People Tuberculosis?
por: McShane, Helen
Publicado: (2020)

Improving Tuberculosis Vaccine Trial Efficiency: A Tough Nut to Crack
por: McShane, Helen
Publicado: (2023)

Invariant NKT Cell Response to Dengue Virus Infection in Human
por: Matangkasombut, Ponpan, et al.
Publicado: (2014)

Local Pulmonary Immunological Biomarkers in Tuberculosis
por: Morrison, Hazel, et al.
Publicado: (2021)

Dengue and Zika Virus Cross-Reactive Human Monoclonal Antibodies Protect against Spondweni Virus Infection and Pathogenesis in Mice
por: Salazar, Vanessa, et al.
Publicado: (2019)

Autoantibody-dependent amplification of inflammation in SLE
por: Lou, Hantao, et al.
Publicado: (2020)

Factors influencing the higher incidence of tuberculosis among migrants and ethnic minorities in the UK
por: Hayward, Sally, et al.
Publicado: (2018)

Antibodies targeting epitopes on the cell-surface form of NS1 protect against Zika virus infection during pregnancy
por: Wessel, Alex W., et al.
Publicado: (2020)

Humoral responses against SARS-CoV-2 Omicron BA.2.11, BA.2.12.1 and BA.2.13 from vaccine and BA.1 serum
por: Huo, Jiandong, et al.
Publicado: (2022)

A New Vaccine for Tuberculosis: The Challenges of Development and Deployment
por: Fletcher, Helen A., et al.
Publicado: (2009)

Tuberculosis vaccines in the era of Covid-19 – what is taking us so long?
por: Dockrell, Hazel M., et al.
Publicado: (2022)

Controlled human infection models in COVID-19 and tuberculosis: current progress and future challenges
por: Morrison, Hazel, et al.
Publicado: (2023)

CryoEM structures of the multimeric secreted NS1, a major factor for dengue hemorrhagic fever
por: Shu, Bo, et al.
Publicado: (2022)

Flavivirus maturation leads to the formation of an occupied lipid pocket in the surface glycoproteins
por: Renner, Max, et al.
Publicado: (2021)

Effects of MVA85A vaccine on tuberculosis challenge in animals: systematic review
por: McShane, Helen, et al.
Publicado: (2016)

A review of preclinical animal models utilised for TB vaccine evaluation in the context of recent human efficacy data()
por: McShane, Helen, et al.
Publicado: (2014)

Towards new TB vaccines
por: Brazier, Benedict, et al.
Publicado: (2020)

Covalently linked dengue virus envelope glycoprotein dimers reduce exposure of the immunodominant fusion loop epitope
por: Rouvinski, Alexander, et al.
Publicado: (2017)

Blockade-of-Binding Activities toward Envelope-Associated, Type-Specific Epitopes as a Correlative Marker for Dengue Virus-Neutralizing Antibody
por: Keelapang, Poonsook, et al.
Publicado: (2023)

The human immune response to tuberculosis and its treatment: a view from the blood
por: Cliff, Jacqueline M, et al.
Publicado: (2015)

Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum
por: Dejnirattisai, Wanwisa, et al.
Publicado: (2022)

Convalescent plasma therapy for the treatment of patients with COVID‐19: Assessment of methods available for antibody detection and their correlation with neutralising antibody levels
por: Harvala, Heli, et al.
Publicado: (2020)

Guillain-Barré Syndrome Following Zika Virus Infection Is Associated With a Diverse Spectrum of Peripheral Nerve Reactive Antibodies
por: Davies, Alexander J., et al.
Publicado: (2022)

Antigenic characterization of SARS-CoV-2 Omicron subvariant BA.4.6
por: Dijokaite-Guraliuc, Aiste, et al.
Publicado: (2022)

A review of clinical models for the evaluation of human TB vaccines
por: O'Shea, Matthew K., et al.
Publicado: (2016)

Aerosol immunisation for TB: matching route of vaccination to route of infection
por: Manjaly Thomas, Zita-Rose, et al.
Publicado: (2015)

Inflammation and immune activation are associated with risk of Mycobacterium tuberculosis infection in BCG-vaccinated infants
por: Satti, Iman, et al.
Publicado: (2022)

Generation of SARS-CoV-2 escape mutations by monoclonal antibody therapy
por: Ragonnet-Cronin, Manon, et al.
Publicado: (2023)

Cholera Toxin Enhances Vaccine-Induced Protection against Mycobacterium Tuberculosis Challenge in Mice
por: Griffiths, Kristin L., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_itb8k8dt5uaercik7sqv77ig6k